期刊文献+

恶性肿瘤的分子靶点检测和靶向治疗 被引量:9

下载PDF
导出
摘要 随着肿瘤分子生物学的发展,分子靶向治疗作为肿瘤治疗的新手段逐渐成为热点。靶向治疗具有特异性强、疗效明显、对正常组织损伤较小等优点。该文对常用的分子靶向治疗药物及其靶点检测做一综述。
作者 邹丹丹 窦骏
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2012年第9期1026-1029,共4页 Chinese Journal of Clinical and Experimental Pathology
  • 相关文献

参考文献30

  • 1Ko E C, Wang X, Fen'one S. Immunotherapy of malignant diseases. Challenges and strategies [J]. Int Arch Allergy Immunol, 2003,132 (4) :294 - 309.
  • 2Ludwig J A, Weinstein J N. Biomarkers in cancer staging, prognosis and treatment selection[J]. Nat Rev Cancer,2005 ( 11 ) ,5 : 845 - 56.
  • 3Wolff A C, Hammond M E, Schwartz J N, et al. American Society of Clinical Oncology/college of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer [ J ]. J Clin 0ncol,2007,25 ( 1 ) : 118 - 45.
  • 4Nakhleh R E, Grimm E E, Idowu M O, et al. Laboratory compliance with the American Society of Clinical Oncology/college of American Pathologists (ASCO/CAP) guidelines for human epidermal growth factor receptor 2 ( HER-2 ) testing : a College of American Pathologists survey of 757 laboratories [ J ]. Arch Pathol Lab Med ,2010,134 (5) :728 - 34.
  • 5Taylor C R, Levenson R M. Quantification of immunohistochemistry-issues concerning methods, utility and semiquantitative assessment Ⅱ [J]. Histopathology,2006,49(4) :411 -24.
  • 6Vogel U F. Confirmation of a low HER-2 positivity rate of breast carcinomas-limitations of immunohistochemistry and in situ hybridization[J]. Diagn Pathol,2010 ,5 :50.
  • 7A11egra C J, Jassup J M, Somerfield M R, et al. American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy[ J]. J Clin Oncol,2009,27 (12) :2091 - 6.
  • 8王建东,周晓军.分子病理检查的规范化问题及建议[J].临床与实验病理学杂志,2012,28(1):64-66. 被引量:8
  • 9谭敏华,雷伟华,谭冬玲,胡志雄,陈威,邹绮嫦.浸润性乳腺癌ER、PR、HER-2、E-cadherin、CK5/6检测与临床预后关系[J].临床与实验病理学杂志,2011,27(9):933-938. 被引量:27
  • 10Menard S, Casalini P, Campiglio M, et al. HER-2 overexpression in various tumor types, focussing on its relationship to the development of invasive breast cancer [ J ]. Ann Oncol, 2001,12 ( S1 ) : 15-9.

二级参考文献59

共引文献103

同被引文献47

引证文献9

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部